Catalysts for Aurobindo Pharma Ltd

NAPROXEN — FDA approval

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval

ACETAZOLAMIDE — FDA approval

FINGOLIMOD HYDROCHLORIDE — FDA approval

Amerisource Health Services LLC recall (Cls II)

Amerisource Health Services LLC recall (Cls II)

Amerisource Health Services LLC recall (Cls II)

Amerisource Health Services LLC recall (Cls II)

Amerisource Health Services LLC recall (Cls II)

Amerisource Health Services LLC recall (Cls II)

Amerisource Health Services LLC recall (Cls II)

ERTUGLIFLOZIN — FDA approval

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

TRAMADOL HYDROCHLORIDE — FDA approval

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

ALENDRONATE SODIUM — FDA approval

MYCOPHENOLATE MOFETIL — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

MYCOPHENOLATE SODIUM — FDA approval

MYCOPHENOLATE MOFETIL — FDA approval

MYCOPHENOLATE MOFETIL — FDA approval

ERTUGLIFLOZIN — FDA approval

FLUTICASONE PROPIONATE — FDA approval

FLUOXETINE HYDROCHLORIDE — FDA approval

FLUOXETINE HYDROCHLORIDE — FDA approval

AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval